Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Boehringer Ingelheim Pharma GmbH and Co. KG | Ingelheim am Rhein, Germany | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMay 15, 2025 · 8 inspections, 1 with FDA action |
Recalls
- Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Atropine: every company that makes it
- Form
- solution, ophthalmic
- Strength
- 10 mg per 1 mL
- Approval
- NDA NDA208151
- On the market since
- Aug 1, 2018
- Package NDCs
0065-0303-55- Official label
- DailyMed (National Library of Medicine), updated Oct 7, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?